This new Aramchol formulation was co-developed by Galmed and Barcode Nanotech, based on Barcode Nanotech's unique and proprietary platform which enables simultaneous screening of hundreds of different ...

Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) today announced that following an application to The Stock Exchange of Hong Kong Limited (the 'Stock ...

According to Mordor Intelligence, the synthetic biology market size was valued at USD 19.75 billion in 2025 and is projected ...

Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy ...

Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to ...

Investors and Advisors, and Life Sciences Analysts are Invited to Attend the New York City Event; Virtual Webcast Link Available Below ...

Chatterjee is a professor of economic development, innovation, and global health economy at the University of Sussex and an ...

CDT holds a 20% equity interest in Sarborg and believes this development represents a meaningful extension of Sarborg's proprietary Signature Intelligence platform beyond its initial pharmaceutical ...

Takeda Pharmaceuticals is set to lay off almost 250 employees in Massachusetts. Here's why.

Add Yahoo as a preferred source to see more of our stories on Google. Belgian biopharmaceutical manufacturer UCB announced plans this week to build a new $2 billion North American campus in Gwinnett ...

This investment was made by LOTTE HOLDINGS Healthcare & Biopharmaceutical Corporate Venture Capital (HB‑CVC), an investment arm of LOTTE HOLDINGS, and will further strengthen Rakuten Medical’s ...